BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 14871818)

  • 1. A genomic approach reveals a novel mitotic pathway in papillomavirus carcinogenesis.
    Thierry F; Benotmane MA; Demeret C; Mori M; Teissier S; Desaintes C
    Cancer Res; 2004 Feb; 64(3):895-903. PubMed ID: 14871818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repression of human papillomavirus oncogenes in HeLa cervical carcinoma cells causes the orderly reactivation of dormant tumor suppressor pathways.
    Goodwin EC; DiMaio D
    Proc Natl Acad Sci U S A; 2000 Nov; 97(23):12513-8. PubMed ID: 11070078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. p53-independent growth regulation of cervical cancer cells by the papillomavirus E6 oncogene.
    Spitkovsky D; Aengeneyndt F; Braspenning J; von Knebel Doeberitz M
    Oncogene; 1996 Sep; 13(5):1027-35. PubMed ID: 8806692
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible repression of papillomavirus oncogene expression in cervical carcinoma cells: consequences for the phenotype and E6-p53 and E7-pRB interactions.
    von Knebel Doeberitz M; Rittmüller C; Aengeneyndt F; Jansen-Dürr P; Spitkovsky D
    J Virol; 1994 May; 68(5):2811-21. PubMed ID: 8151752
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus E7 repression in cervical carcinoma cells initiates a transcriptional cascade driven by the retinoblastoma family, resulting in senescence.
    Johung K; Goodwin EC; DiMaio D
    J Virol; 2007 Mar; 81(5):2102-16. PubMed ID: 17182682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of cervical carcinoma cell line proliferation by the introduction of a bovine papillomavirus regulatory gene.
    Hwang ES; Riese DJ; Settleman J; Nilson LA; Honig J; Flynn S; DiMaio D
    J Virol; 1993 Jul; 67(7):3720-9. PubMed ID: 8389903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new E6/P63 pathway, together with a strong E7/E2F mitotic pathway, modulates the transcriptome in cervical cancer cells.
    Teissier S; Ben Khalifa Y; Mori M; Pautier P; Desaintes C; Thierry F
    J Virol; 2007 Sep; 81(17):9368-76. PubMed ID: 17582001
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcriptome signature of irreversible senescence in human papillomavirus-positive cervical cancer cells.
    Wells SI; Aronow BJ; Wise TM; Williams SS; Couget JA; Howley PM
    Proc Natl Acad Sci U S A; 2003 Jun; 100(12):7093-8. PubMed ID: 12756294
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of HPV oncoproteins and cellular factors in maintenance of hTERT expression in cervical carcinoma cells.
    Jeong Seo E; Jung Kim H; Jae Lee C; Tae Kang H; Seong Hwang E
    Gynecol Oncol; 2004 Jul; 94(1):40-7. PubMed ID: 15262117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
    Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
    Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of the human papillomavirus type 16 E2 gene protects cervical carcinoma cells from E2F-induced apoptosis.
    Sanchez-Perez AM; Soriano S; Clarke AR; Gaston K
    J Gen Virol; 1997 Nov; 78 ( Pt 11)():3009-18. PubMed ID: 9367388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of BPV1 E2-mediated inhibition of E6/E7 expression in HPV16-positive cervical carcinoma cells.
    Moon MS; Lee CJ; Um SJ; Park JS; Yang JM; Hwang ES
    Gynecol Oncol; 2001 Feb; 80(2):168-75. PubMed ID: 11161855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPV-16 E2 physical status and molecular evolution in vivo in cervical carcinomas.
    Kahla S; Kochbati L; Chanoufi MB; Maalej M; Oueslati R
    Int J Biol Markers; 2014 Mar; 29(1):e78-85. PubMed ID: 24170557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiation-enhanced expression of E6/E7 transforming oncogenes of human papillomavirus-16 in human cervical carcinoma.
    Santin AD; Hermonat PL; Ravaggi A; Chiriva-Internati M; Pecorelli S; Parham GP
    Cancer; 1998 Dec; 83(11):2346-52. PubMed ID: 9840534
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of the retinoblastoma pathway in senescence triggered by repression of the human papillomavirus E7 protein in cervical carcinoma cells.
    Psyrri A; DeFilippis RA; Edwards AP; Yates KE; Manuelidis L; DiMaio D
    Cancer Res; 2004 May; 64(9):3079-86. PubMed ID: 15126344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transactivation-competent bovine papillomavirus E2 protein is specifically required for efficient repression of human papillomavirus oncogene expression and for acute growth inhibition of cervical carcinoma cell lines.
    Goodwin EC; Naeger LK; Breiding DE; Androphy EJ; DiMaio D
    J Virol; 1998 May; 72(5):3925-34. PubMed ID: 9557678
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of HPV E6 and E7 expression by BAF53 depletion in cervical cancer cells.
    Lee K; Lee AY; Kwon YK; Kwon H
    Biochem Biophys Res Commun; 2011 Aug; 412(2):328-33. PubMed ID: 21821000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of the integrated papillomavirus E6/E7 promoter is required for growth suppression of cervical cancer cells.
    Francis DA; Schmid SI; Howley PM
    J Virol; 2000 Mar; 74(6):2679-86. PubMed ID: 10684283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced oncogenicity of Asian-American human papillomavirus 16 is associated with impaired E2 repression of E6/E7 oncogene transcription.
    Ordóñez RM; Espinosa AM; Sánchez-González DJ; Armendáriz-Borunda J; Berumen J
    J Gen Virol; 2004 Jun; 85(Pt 6):1433-1444. PubMed ID: 15166426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Caveolin-1 expression is down-regulated in cells transformed by the human papilloma virus in a p53-dependent manner. Replacement of caveolin-1 expression suppresses HPV-mediated cell transformation.
    Razani B; Altschuler Y; Zhu L; Pestell RG; Mostov KE; Lisanti MP
    Biochemistry; 2000 Nov; 39(45):13916-24. PubMed ID: 11076533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.